Journal article
Single-center experience with botulinum toxin endoscopic detrusor injection for the treatment of congenital neuropathic bladder in children: Effect of dose adjustment, multiple injections, and avoidance of reconstructive procedures
Abstract
OBJECTIVE: Since 2007, intra-detrusor OnabotulinumtoxinA (OnabotA) injections have been selectively offered at our institution for cases in which maximal anticholinergic therapy failed or was not tolerated. Herein we present our experience with this approach.
MATERIALS AND METHODS: We prospectively obtained data on 17 patients who underwent OnabotA injections over a 4-year period. Demographic information, number of injections, and dose …
Authors
Figueroa V; Romao R; Salle JLP; Koyle MA; Braga LHP; Bägli DJ; Lorenzo AJ
Journal
Journal of Pediatric Urology, Vol. 10, No. 2, pp. 368–373
Publisher
Elsevier
Publication Date
April 2014
DOI
10.1016/j.jpurol.2013.10.011
ISSN
1477-5131
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Administration, IntravesicalAdolescentBotulinum Toxins, Type ACanadaChildChild, PreschoolCohort StudiesCystoscopyDose-Response Relationship, DrugDrug Administration ScheduleFemaleFollow-Up StudiesHospitals, PediatricHumansMaleMaximum Tolerated DoseNeuromuscular AgentsPatient SafetyProspective StudiesPlastic Surgery ProceduresRisk AssessmentSeverity of Illness IndexTime FactorsTreatment OutcomeUrinary Bladder, NeurogenicUrodynamics